RP-L201

Phase 1Withdrawn

0 watching 0 views this week💤 Quiet

Hype Score

Development Stage

✓

Pre-clinical

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Leukocyte Adhesion Defect - Type I

Conditions

Leukocyte Adhesion Defect - Type I

Trial Timeline

Apr 15, 2019 → Oct 1, 2021

NCT ID

NCT03825783

About RP-L201

RP-L201 is a phase 1 stage product being developed by Rocket Pharmaceuticals for Leukocyte Adhesion Defect - Type I. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT03825783. Target conditions include Leukocyte Adhesion Defect - Type I.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (2)

NCT ID	Phase	Status	Start	Completion	Indication
NCT03812263	Phase 1/2	Completed	Aug 30, 2019	Sep 12, 2023	Leukocyte Adhesion Defect - Type I
NCT03825783	Phase 1	Withdrawn	Apr 15, 2019	Oct 1, 2021	Leukocyte Adhesion Defect - Type I

Competing Products

1 competing product in Leukocyte Adhesion Defect - Type I

See all competitors

Product	Company	Stage	Hype Score
RP-L201	Rocket Pharmaceuticals	Phase 1/2	33

Other Products from Rocket Pharmaceuticals